Doxycycline in renal failure

References

• Bateman J. C., Barberio J. R., Grice P., Klopp C. T., Pierpont H. Fatal complications of intensive antibiotic therapy in patients with neoplastic disease. Arch, intern. Med. 1952; 90: 7631. Bateman J. C., Barberio J. R., Grice P., Klopp C. T., Pierpont H. Fatal complications of intensive antibiotic therapy in patients with neoplastic disease. Arch, intern. Med. 1952; 90: 763
   Web of Science ®Google Scholar
• Beard N. S., Jr., Armentrout S. A., Weisberger A. S. Inhibition of mammalian protein synthesis by antibiotics. Pharmacol. Rev. 1969; 21: 2132. Beard N. S., Jr., Armentrout S. A., Weisberger A. S. Inhibition of mammalian protein synthesis by antibiotics. Pharmacol. Rev. 1969; 21: 213
   PubMed Web of Science ®Google Scholar
• Benitz K.-R, Diermeier H. F. Renal toxicity of tetracycline degradation products. Proc. soc. exp. Biol. Med. 1969; 115: 9303. Benitz K.-R, Diermeier H. F. Renal toxicity of tetracycline degradation products. Proc. soc. exp. Biol. Med. 1969; 115: 930
   Google Scholar
• Ericsson H. M., Sherris J. C. Antibiotic sensitivity testing. Report of an international collaborative study. Acta pathol. microbiol. scand. B 1971, Suppl.: 2174. Ericsson H. M., Sherris J. C. Antibiotic sensitivity testing. Report of an international collaborative study. Acta pathol. microbiol. scand. B 1971, Suppl.: 217
   Google Scholar
• Fabre J., Pitton J. S., Virieux C., Laurencet F. L., Bernhardt J. P., Godel J. C. Doxycycline: absorption, distribution and excretion of a new broad-spectrum antibiotic in man. Schweiz. med. Wschr. 1967; 97: 9155. Fabre J., Pitton J. S., Virieux C., Laurencet F. L., Bernhardt J. P., Godel J. C. Doxycycline: absorption, distribution and excretion of a new broad-spectrum antibiotic in man. Schweiz. med. Wschr. 1967; 97: 915
   PubMedGoogle Scholar
• Finkelstein N., Aliminosa L. M., Smith H. W. The renal clearances of hippuric acid and pyridone derivatives. Amer. J. Physiol. 1941; 133: 2766. Finkelstein N., Aliminosa L. M., Smith H. W. The renal clearances of hippuric acid and pyridone derivatives. Amer. J. Physiol. 1941; 133: 276
   Google Scholar
• Frimpter G. W., Timpanelli A. E., Eisenmenger W. J., Stein H. S., Ehrlich L. I. Reversible “Fanconi syndrome” caused by degraded tetracycline. J. Amer. med. Ass. 1963; 184: 1117. Frimpter G. W., Timpanelli A. E., Eisenmenger W. J., Stein H. S., Ehrlich L. I. Reversible “Fanconi syndrome” caused by degraded tetracycline. J. Amer. med. Ass. 1963; 184: 111
   PubMed Web of Science ®Google Scholar
• George C. R. P., Evans R. A. Tetracycline toxicity in renal failure. Med. J. Aust. 1971; 2: 12718. George C. R. P., Evans R. A. Tetracycline toxicity in renal failure. Med. J. Aust. 1971; 2: 1271
   Google Scholar
• Gross J. M. Fanconi syndrome (adult type) developing secondary to the ingestion of outdated tetracycline. Ann. intern. Med. 1963; 58: 5239. Gross J. M. Fanconi syndrome (adult type) developing secondary to the ingestion of outdated tetracycline. Ann. intern. Med. 1963; 58: 523
   PubMed Web of Science ®Google Scholar
• Laurencet F. L., Fabre J. Influence de Pinsuflflsance renale sur le comportement de la doxycycline. J. Urol. Niphrol 1968; 74: 103810. Laurencet F. L., Fabre J. Influence de Pinsuflflsance renale sur le comportement de la doxycycline. J. Urol. Niphrol 1968; 74: 1038
   PubMedGoogle Scholar
• Lee P., Crutch E. R., Morrison R. B. Doxycycline: studies in normal subjects and patients with renal failure. N.Z. med. J. 1972; 75: 35511. Lee P., Crutch E. R., Morrison R. B. Doxycycline: studies in normal subjects and patients with renal failure. N.Z. med. J. 1972; 75: 355
   PubMed Web of Science ®Google Scholar
• Little P. J., Bailey R. R. Tetracyclines and renal failure. N.Z. med. J. 1970; 11: 18312. Little P. J., Bailey R. R. Tetracyclines and renal failure. N.Z. med. J. 1970; 11: 183
   Google Scholar
• Mahon W. A., Wittenberg J. V.P., Tuffnel P. G. Studies on the absorption and distribution of doxycycline in normal patients and in patients with severely impaired renal function. Cimucl. med. Ass. J. 1970; 103: 103113. Mahon W. A., Wittenberg J. V.P., Tuffnel P. G. Studies on the absorption and distribution of doxycycline in normal patients and in patients with severely impaired renal function. Cimucl. med. Ass. J. 1970; 103: 1031
   PubMed Web of Science ®Google Scholar
• Mannhart M., Dettli L., Spring P. Die Elimination des Doxyzyklins und ihre Beeinflussung durch die Hamodialyse bei anurischen Patienten. Schweiz. med. Wschr. 1971; 101: 2314. Mannhart M., Dettli L., Spring P. Die Elimination des Doxyzyklins und ihre Beeinflussung durch die Hamodialyse bei anurischen Patienten. Schweiz. med. Wschr. 1971; 101: 23
   Google Scholar
• Mér G., Laurencet F. L., Rudhardt M., Chuit A., Fabre J. Behaviour of doxycycline in renal insufficiency. Helv. med. Acta 1969; 35: 12415. Mér G., Laurencet F. L., Rudhardt M., Chuit A., Fabre J. Behaviour of doxycycline in renal insufficiency. Helv. med. Acta 1969; 35: 124
   PubMedGoogle Scholar
• Phillips M. E., Eastwood J. B., Curtis J. R., Gower P. E., de Wardener H. E. Tetracycline poisoning in renal failure. Brit. med. J. 1974; 2: 14916. Phillips M. E., Eastwood J. B., Curtis J. R., Gower P. E., de Wardener H. E. Tetracycline poisoning in renal failure. Brit. med. J. 1974; 2: 149
   PubMed Web of Science ®Google Scholar
• Porpáczy P. Doxycycline (Vibramycin ®) bei eingeschränkter Nierenfunktion. Wien. klin. Wschr. 1970; 82: 71017. Porpáczy P. Doxycycline (Vibramycin ®) bei eingeschränkter Nierenfunktion. Wien. klin. Wschr. 1970; 82: 710
   PubMedGoogle Scholar
• Schach von Wittenau M., Twomey T. The disposition of doxycycline by man and dog. Chemotherapy 1971; 16: 21718. Schach von Wittenau M., Twomey T. The disposition of doxycycline by man and dog. Chemotherapy 1971; 16: 217
   PubMed Web of Science ®Google Scholar
• Schoog M., Dimmling T., Winkler E., Weih H. Pharmacological studies in humans on the tolerance of intravenously administered doxycycline. Arzneim.-forsch. 1971; 21: 145919. Schoog M., Dimmling T., Winkler E., Weih H. Pharmacological studies in humans on the tolerance of intravenously administered doxycycline. Arzneim.-forsch. 1971; 21: 1459
   PubMed Web of Science ®Google Scholar
• Schreiner G. E. Determination of inulin by means of resorcinol. Proc. soc. exp. Biol. Med. 1950; 74: 11720. Schreiner G. E. Determination of inulin by means of resorcinol. Proc. soc. exp. Biol. Med. 1950; 74: 117
   PubMed Web of Science ®Google Scholar
• Shils M. E. Some metabolic aspects of tetracyclines. Clin. Pharmacol. Ther. 1962; 3: 32121. Shils M. E. Some metabolic aspects of tetracyclines. Clin. Pharmacol. Ther. 1962; 3: 321
   PubMed Web of Science ®Google Scholar
• Shils M. E. Renal disease and the metabolic effects of tetracycline. Ann. intern. Med. 1963; 58: 38922. Shils M. E. Renal disease and the metabolic effects of tetracycline. Ann. intern. Med. 1963; 58: 389
   PubMed Web of Science ®Google Scholar
• Stein W., Schoog M., Franz H. E. Doxycyclin-Serumspiegel bei nieren-insuffizienten Patienten. Arzneim.-forsch. 1969; 19: 82723. Stein W., Schoog M., Franz H. E. Doxycyclin-Serumspiegel bei nieren-insuffizienten Patienten. Arzneim.-forsch. 1969; 19: 827
   PubMedGoogle Scholar
• Vetter D., Reutter F. W. Klinisch-therapeutische Erfahrungen mit Vibramycin® bei der Behandlung von Harnwegsinfektionen. Ther. Umsch. 1970; 27: 33124. Vetter D., Reutter F. W. Klinisch-therapeutische Erfahrungen mit Vibramycin® bei der Behandlung von Harnwegsinfektionen. Ther. Umsch. 1970; 27: 331
   PubMedGoogle Scholar
• Womack C. R., Jackson G. G., Gocke T. M., Kass E. H., Haight T. H., Finland M. Terramycin therapy of urinary tract infections. Arch, intern. Med. 1952; 89: 24025. Womack C. R., Jackson G. G., Gocke T. M., Kass E. H., Haight T. H., Finland M. Terramycin therapy of urinary tract infections. Arch, intern. Med. 1952; 89: 240
   Web of Science ®Google Scholar